Antihistamine study
This article was originally published in The Tan Sheet
Executive Summary
The Transportation Secretary "shall review available information on the effects of medications (including antihistamines) on driver fatigue, awareness and performance and shall consider encouraging, if appropriate, the use of nonsedating medications (including nonsedating antihistamines) as a means of reducing the adverse effects of the use of other medications by drivers," under the conference report to the transportation bill (105-555) passed by the House and Senate May 22 and signed into law (105-178) June 9. The measure potentially could benefit Claritin (loratidine) manufacturer Schering-Plough, which is understood to have backed the provision...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning